The Biden administration said Wednesday it’s tapping into a national stockpile of Tamiflu to increase the supply of the antiviral in response to soaring demand tied to the devastating flu season.
Pharmacists have reported a shortage of oseltamivir, which is sold under the brand name Tamiflu to treat influenza A and B in people at higher risk of complications from the illness.
The shortage coincides with a flu season that hit early and hard this year. It may be peaking in parts of the U.S., but hospitals are admitting over 20,000 patients per week.
Health and Human Services Secretary Xavier Becerra said the decision is an extension of his Dec.